Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine patient-controlled intravenous analgesia plus pulsed radiofrequency for zoster-associated pain
ChiCTR2400094022Phase 4Recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in herpes zoster-associated pain and postherpetic neuralgia (PHN) (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoint: Numeric Rating Scale pain score. Started Dec 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
herpes zoster-associated painpostherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2400094022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094022.